[Edaily Reporter Kwon Oh Seok ] #Nota Inc.’s stock price is surging in early trading. It appears that buying interest is surging following news that the company’s solution has been listed on the Naver Cloud Marketplace. According to MP Doctor on the 2nd, as of 9:09 a.m., Nota Inc.’s stock is trading at 23,900 won, up 12.47% from the previous trading day. Earlier today, Nota Inc. issued a press release announcing, “We have listed ‘NVA (Nota Vision Agent),’ a video surveillance solution based on a Vision Language Model (VLM), on the Naver Cloud Marketplace.” The Naver Cloud Marketplace is an online store that allows corporate and institutional customers to explore and adopt various solutions and services built on the Naver Cloud platform. NVA is a video surveillance solution that goes beyond traditional computer vision (CV)-based object detection; it utilizes VLM to understand the situations and context within videos and analyze and summarize abnormal situations. It is characterized by its ability to provide text-based explanations of complex situations and identify suspicious incidents. This listing is expected to serve as an opportunity to expand NVA’s customer reach and sales channels. Chae Myeong-su, CEO of Nota Inc., stated, “NVA is Nota Inc.’s core solution that is growing rapidly, having expanded its scope of application to domestic companies and public institutions as well as the overseas traffic control sector in less than a year since its launch.” He added, “Through this listing on the Naver Cloud Marketplace, we will expand our customer base in the private, financial, and public sectors and actively explore new cloud-based revenue channels.”
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…